Top Premarket Decliners

MT Newswires Live07-24 19:43

VYNE Therapeutics (VYNE) shares were down 41% in Friday premarket trading as the company's 1-for-50 reverse stock split is expected to become effective, with the shares to begin trading on a post-split basis on Monday.

China SXT Pharmaceuticals (SXTC) stock was down 27% after the company entered into a definitive securities purchase agreement for a registered direct offering of 4.5 million units at $2.00 per unit.

Codexis (CDXS) shares were down 26% after the company priced an underwritten public offering of about 16.7 million common shares at $1.50 per share.

TDH (PETZ) stock was down 19%, reversing the previous session's 13% decline.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment